Pfizer

FDA Expands Review of Possible COVID Vaccine-Linked Deaths to Multiple Age Groups

The agency faces pressure to disclose case-level evidence after an internal memo cited unverified pediatric deaths, prompting proposals for tougher vaccine standards.